Title	Publication Date	Language	Citations
Therapeutic concordance of two portable monitors and two routine automatic oral anticoagulant monitoring systems using as reference the manual prothrombin time technique	2003/01/01		4
Platinum compounds and therapy related acute promyelocytic leukemia	2002/01/01		4
Comparative genomic hybridization and multiplex-fluorescence in situ hybridization: an appraisal in elderly patients with acute myelogenous leukemia	2002/01/01		4
No BCL-2 protein over expression but BCL-2/IgH rearrangements in B cells of patients with persistent polyclonal B-cell lymphocytosis	2001/01/01		4
Refractory cold agglutinin-immunohaemolytic anaemia associated to marginal zone lymphoma responding to rituximab	2003/01/01		4
Effect of adenovirus-mediated p27 gene expression on the proliferation and apoptosis of HL-60 and Raji cell lines	2004/01/01		4
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival	2004/01/01		4
Immune-mediated thrombocytopenic purpura associated with Toxoplasma gondii infection in an immunocompetent patient	2004/01/01		4
Repeated rituximab maintenance courses in fludarabine-failed young patients with chronic lymphocytic leukaemia responding to FAND chemotherapy	2004/01/01		4
A review of recruitment criteria, patient characteristics and results of CHOP chemotherapy in prospective randomized phase III clinical trials for aggressive non-Hodgkin's lymphoma	2003/01/01		4
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation	2004/01/01		3
Recurrent psychotic episodes in a patient who received rituximab for the treatment of non-Hodgkin's lymphoma	2004/01/01		3
Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia	2004/01/01		3
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation	2004/01/01		3
Future prospects for fludarabine-containing regimens in the treatment of hematological cancers	2004/01/01		3
Clinical experience with fludarabine in indolent non-Hodgkin's lymphoma	2004/01/01		3
Intravascular lymphoma – a rare cause of hemolytic anemia and neurologic disorders	2004/01/01		3
Mortality in severe, non aggressively treated adult autoimmune thrombocytopenia	2003/01/01		3
Therapy-related acute myeloid leukemia with t(9;11)(p12;q23) in a patient treated for acute promyelocytic leukemia	2003/01/01		3
Factors affecting hematopoietic recovery after autologous peripheral blood progenitor-cell transplantation in aggressive non-Hodgkin's lymphoma: a prospective study of 123 patients	2001/01/01		3
Selective inactivation of Von Willebrand factor binding to glycoprotein IIb/IIIa and to inhibitor monoclonal antibody 9 by site-directed mutagenesis	2001/01/01		3
Detection of BCR/ABL rearrangements in adult acute lymphoblastic leukemia using a highly sensitive interphase fluorescence in situ hybridization method (D-FISH)	2001/01/01		3
Thrombotic thrombocytopenic purpura	2004/01/01		3
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation	2004/01/01		3
Erythropoietin pathophysiology and erythropoietin deficiency anemia	2004/01/01		3
Molecular pathology of thalassemia intermedia	2004/01/01		3
Antiphospholipid syndrome	2004/01/01		3
Reduced intensity transplantation: where are we now?	2004/01/01		3
Retreatment with rituximab alone induces sustained remission in a patient with follicular lymphoma with multiple extranodal sites of involvement, relapsing soon after primary treatment with fludarabine–rituximab	2003/01/01		3
Prognostic relevance of soluble CD23 levels in CLL	2001/01/01		3